Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.55
-1.00 (-3.50%)
Mar 9, 2026, 12:31 PM CST

Prince Pharmaceutical Revenue

Prince Pharmaceutical had revenue of 448.06M TWD in the half year ending June 30, 2025, with 25.86% growth. This brings the company's revenue in the last twelve months to 798.27M, up 8.29% year-over-year. In the year 2024, Prince Pharmaceutical had annual revenue of 690.03M, down -8.40%.

Revenue (ttm)
798.27M
Revenue Growth
+8.29%
P/S Ratio
1.26
Revenue / Employee
3.80M
Employees
210
Market Cap
1.01B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024690.03M-63.30M-8.40%
Dec 31, 2023753.33M40.80M5.73%
Dec 31, 2022712.53M271.45M61.54%
Dec 31, 2021441.08M145.28M49.12%
Dec 31, 2020295.79M46.19M18.50%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Mediera 229.85M
Original BioMedicals 381.00K
Anxo Pharmaceutical 883.22M
Excelsior Biopharma 898.26M
DV Biomed 712.61M
Winston Medical Supply 724.35M
Bioray Biotech 230.06M
General Biologicals 251.38M
Revenue Rankings